HIGHLIGHTS
- who: Vincenzo Giambra and colleagues from the Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies, Fondazione IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy Department of Public Health, University "Federico II", Napoli, Italy have published the article: Effectiveness of Booster Dose of Anti SARS-CoV-2 BNT162b2 in Cirrhosis: Longitudinal Evaluation of Humoral and Cellular Response, in the Journal: Vaccines 2022, 10, 1281. of /2022/
- how: In this study T-cell function tests were performed but antigen-specific B-cell response was not investigated.
SUMMARY
To determine the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.